Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESPOND pilot trial of early inotropes versus standard fluid resuscitation in pediatric septic shock
ACTRN12619000828123Phase 2Recruiting
- Sponsor
- The University of Queensland
- Start
- Jul 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of epinephrine in sepsis and septic shock (2 arms), sponsored by The University of Queensland. Primary endpoints: Protocol compliance feasibility and Survival free of organ dysfunction. Started Jul 2019; status: recruiting.
02
Drugs
epinephrine
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on ACTRN12619000828123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000828123.